How Much Bac Water for BPC-157?
Reconstituting a 5mg BPC-157 vial with 2.0 mL of bacteriostatic water creates a 2.5 mg/mL (2,500 mcg/mL) concentration. A 250 mcg dose equals 10 units (0.10 mL) on a standard U-100 syringe.
Bacteriostatic water for injection dissolves lyophilized BPC-157 peptide powder into an aqueous solution. It contains 0.9% (9 mg/mL) benzyl alcohol preservative to inhibit microbial growth in multi-dose containers. The volume of diluent added dictates the final concentration in milligrams per milliliter (mg/mL) and microgram delivery per syringe graduation mark. On a standard U-100 insulin syringe, 100 units equal 1.0 mL (0.01 mL per unit mark).
BPC-157 Dilution Matrix for 2 mg, 5 mg, and 10 mg Vials
| Vial Size | BAC Water Added | Concentration | Micrograms per Unit | Example 250 mcg Draw |
|---|---|---|---|---|
| 2 mg | 1.0 mL | 2.00 mg/mL (2,000 mcg/mL) | 20.0 mcg/unit | 12.5 units (0.125 mL) |
| 2 mg | 2.0 mL | 1.00 mg/mL (1,000 mcg/mL) | 10.0 mcg/unit | 25.0 units (0.25 mL) |
| 2 mg | 3.0 mL | 0.67 mg/mL (667 mcg/mL) | 6.7 mcg/unit | 37.5 units (0.375 mL) |
| 5 mg | 1.0 mL | 5.00 mg/mL (5,000 mcg/mL) | 50.0 mcg/unit | 5.0 units (0.05 mL) |
| 5 mg | 2.0 mL | 2.50 mg/mL (2,500 mcg/mL) | 25.0 mcg/unit | 10.0 units (0.10 mL) |
| 5 mg | 3.0 mL | 1.67 mg/mL (1,667 mcg/mL) | 16.7 mcg/unit | 15.0 units (0.15 mL) |
| 10 mg | 1.0 mL | 10.00 mg/mL (10,000 mcg/mL) | 100.0 mcg/unit | 2.5 units (0.025 mL) |
| 10 mg | 2.0 mL | 5.00 mg/mL (5,000 mcg/mL) | 50.0 mcg/unit | 5.0 units (0.05 mL) |
| 10 mg | 3.0 mL | 3.33 mg/mL (3,333 mcg/mL) | 33.3 mcg/unit | 7.5 units (0.075 mL) |
Worked Calculation: Comparing 2.0 mL vs 1.0 mL in a 5 mg Vial
- Vial mass: 5 mg (5,000 mcg) BPC-157 powder
- Volume Option A: 2.0 mL bacteriostatic water
- Volume Option B: 1.0 mL bacteriostatic water
- Illustrative target draw: 250 mcg (0.25 mg)
- Syringe standard: U-100 insulin syringe (100 units = 1.0 mL)
- Option A (2.0 mL): Concentration = 5 mg ÷ 2.0 mL = 2.5 mg/mL (2,500 mcg/mL). Since 100 units = 1.0 mL, unit resolution is 2,500 mcg ÷ 100 = 25 mcg/unit. For 250 mcg, draw 250 mcg ÷ 25 mcg/unit = 10.0 units (0.10 mL).
- Option B (1.0 mL): Concentration = 5 mg ÷ 1.0 mL = 5.0 mg/mL (5,000 mcg/mL). Unit resolution is 5,000 mcg ÷ 100 = 50 mcg/unit. For 250 mcg, draw 250 mcg ÷ 50 mcg/unit = 5.0 units (0.05 mL).
- Reverse verification: For Option A, 10 units × 25 mcg/unit = 250 mcg (0.10 mL × 2.5 mg/mL = 0.25 mg). For Option B, 5 units × 50 mcg/unit = 250 mcg (0.05 mL × 5.0 mg/mL = 0.25 mg).
With 2.0 mL of diluent, draw 10.0 units (0.10 mL). With 1.0 mL of diluent, draw 5.0 units (0.05 mL).
Note: Deterministic arithmetic verification confirms mathematical parity across both reconstitution volumes.
Step-by-Step Instructions
- Select Diluent Volume Based on Resolution
Select 1.0 mL, 2.0 mL, or 3.0 mL based on target draw size. For a 5 mg vial, 2.0 mL produces an even 25 mcg per syringe unit mark, allowing accurate 10-unit draws for 250 mcg.
- Sanitize and Draw Diluent
Disinfect both vial rubber stoppers using 70% isopropyl alcohol prep pads. Using a sterile syringe, draw the exact diluent volume.
- Introduce Diluent Slowly
Direct liquid stream slowly down the interior vial wall to prevent excessive bubbling. Swirl gently until the powder fully dissolves. Do not shake.
Common Mistakes to Avoid
- ⚠️Microgram versus Milligram Scale Confusion
Confusing mcg with mg is a critical 1,000-fold arithmetic failure. 250 mcg equals 0.25 mg, not 2.5 mg. Always verify unit conversions before calculating syringe barrel marks.
- ⚠️Applying Mismatched Volume Math
If you reconstitute a 5 mg vial with 1.0 mL of water but calculate syringe marks using 2.0 mL numbers, a 10-unit draw delivers 500 mcg instead of the intended 250 mcg.
- ⚠️Using Preservative-Free Sterile Water for Multi-Dose Storage
Single-use sterile water lacks antimicrobial agents. For multi-dose punctured vials stored under refrigeration, USP standards require bacteriostatic water with 0.9% benzyl alcohol.
- ⚠️Syringe Scale Discrepancies (U-100 vs U-40)
All calibrations assume U-100 insulin syringes (100 units = 1.0 mL). Using a U-40 veterinary syringe creates a 2.5-fold volumetric overdose.
Why It Matters
The volume of bacteriostatic water added governs measurement resolution. Adding 2.0 mL to a 5 mg vial establishes a 2.5 mg/mL concentration (25 mcg per unit), where a 1-unit graduation variance represents only 25 mcg. Reconstituting with 1.0 mL doubles the concentration to 5.0 mg/mL (50 mcg per unit), doubling the relative measurement error of any slight graduation reading discrepancy.
Accurate dilution simplifies measuring microgram laboratory draws. For custom vial sizes and draw calculations, use the full BPC-157 dosage calculator. If researching co-lyophilized combinations, consult the BPC-157 & TB-500 blend calculator, or review standard protocols in how to reconstitute peptides.
Calculate Your Exact Dosage
Use our interactive calculator to get instant reconstitution and draw units.
- A clinical dose, treatment schedule, or medical recommendation.
- Which water volume is medically indicated for your research protocol.
- Therapeutic efficacy or safety in humans (BPC-157 is an unapproved peptide categorized under FDA 503A Category 2).
This tool converts volumetric liquid measurements and syringe tick marks only. It does not provide medical guidance, dosing schedules, or clinical administration protocols. Review our Medical & Research Disclaimer.
Related Questions
Scientific & Regulatory References
View Full Sources Registry→The mathematical formulas on this page are deterministic volumetric conversions. Non-mathematical parameters, regulatory status notes, and chemical safety guidelines are referenced directly to the primary sources cataloged below:
- [1]Safety Risks Associated with Certain Bulk Drug Substances Nominated for 503A/503B CompoundingU.S. Food and Drug Administration•Type: fda communication•Verified: 2026-10-20
FDA Category 2 classification covering safety considerations for BPC-157, AOD-9604, and CJC-1295.
- [2]World Anti-Doping Code International Standard: Prohibited List (S2: Peptide Hormones)World Anti-Doping Agency (WADA)•Type: regulatory list•Verified: 2026-10-20
Prohibits growth hormone secretagogues (GHS), GH fragments, BPC-157, TB-500, and metabolic modulators.
- [3]Stable Gastric Pentadecapeptide BPC 157 in Clinical Pharmacology and Gastric ProtectionCurrent Pharmaceutical Design (PubMed PMID: 20388954)•Type: peer reviewed•Verified: 2026-10-20
Evaluation of 15-amino acid sequence stability in gastric acid and neutral buffered aqueous solution.
- [4]Bacteriostatic Water for Injection, USP Multi-Dose Prescribing DetailsU.S. National Library of Medicine (DailyMed / Hospira / Pfizer)•Type: fda label•Verified: 2026-10-20
Sterile multi-dose diluent specification containing 0.9% (9 mg/mL) benzyl alcohol preservative.
- [5]Embecta Ultra-Fine™ U-100 Insulin Syringe Product Specificationsembecta (formerly BD Diabetes Care)•Type: manufacturer spec•Verified: 2026-11-08
Manufacturer specifications for sterile single-use U-100 insulin syringes (0.3 mL, 0.5 mL, and 1.0 mL capacities with 1-unit and 1/2-unit scales).